You are here: Industry Insights > Mylan

News List

FDA Approves Biosimilar Interchangeable Insulin Treatment for Diabetes americanpharmaceuticalreview
July 30, 2021
The FDA approved the first interchangeable biosimilar product, Mylan’s Semglee (insulin glargine-yfgn). Semglee (insulin glargine-yfgn) is both biosimilar to and interchangeable with Lantus (insulin glargine).
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms expresspharma
April 09, 2021
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun Pharma - have a monthly production capacity of 31.60 lakh vials.
Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake expresspharma
March 17, 2021
Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s Novolog/NovoRapid (insulin aspart).
US court rules in favour of AstraZeneca in Symbicort patent litigation pharmaceutical-technology
March 04, 2021
A US district court for the Northern District of West Virginia has decided in favour of AstraZeneca in a patent litigation lawsuit against Mylan Pharmaceuticals, which is now part of Viatris, and Kindeva Drug Delivery.
USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan expresspharma
December 28, 2020
To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the standard review process.
Biocon Biologics, Mylan get CHMP recommendation for approval of biosimilar insulin Aspart expresspharma
December 14, 2020
Biocon Biologics (a subsidiary of Biocon), and Mylan (a subsidiary of Viatris) have received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending approval of the market authorisation ..
Mylan Appoints Head of Capital Markets contractpharma
November 04, 2020
Bill Szablewski joins the company from Bristol Myers Squibb where he served as Assistant Treasurer, Capital Markets.
CSIR and Mylan in partnership to develop therapeutic options for COVID–19 management expresspharma
September 24, 2020
The application for the clinical trials has been submitted to DCGI for regulatory approval.
Mylan, Pfizer Receive EC Approval for Proposed Combination of Mylan and Upjohn americanpharmaceuticalreview
September 22, 2020
Mylan and Pfizer announced the companies have received final approval from the European Commission (EC) for the proposed combination of Mylan and Pfizer's Upjohn business.
Mylan to acquire Aspen’s thrombosis business for $757m pharmaceutical-technology
September 18, 2020
Mylan has agreed to acquire Aspen Pharmacare’s thrombosis business-related intellectual property and commercialisation rights in Europe for €641.9m ($757m).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page